-
Standford University Med School to Host Levosimendan Phase 2 Trial
Stanford University School of Medicine is the first clinical site for a Phase 2 trial testing Tenax’s levosimendan candidate for the treatment of PH-HFpEF. Click here to read more.
What other clinical trials are you interested in reading about?
Sorry, there were no replies found.
Log in to reply.